ArticleFrontiers in oncology2024
An integrated method for detecting lung cancer via CT scanning via optimization, deep learning, and IoT data transmission.
Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A radiomics nomogram integrated with radiological features for preoperative prediction of lung nodule invasiveness: comparison with Lung-RADS.Translational lung cancer research · 2026Article
- Interpretable hybrid ensemble with attention-based fusion and EAOO-GA optimization for lung cancer detection.Scientific reports · 2026Article
- Impact of CT Intensity and Contrast Variability on Deep-Learning-Based Lung-Nodule Detection: A Systematic Review of Preprocessing and Harmonization Strategies (2020-2025).Diagnostics (Basel, Switzerland) · 2026Review
- Article
- Artificial Intelligence for the Diagnosis and Management of Cancers: Potentials and Challenges.MedComm · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With its increasing global prevalence, lung cancer remains a critical health concern. Despite the advancement of screening programs, patient selection and risk stratification pose significant challenges. This study addresses the pressing need for early detection through a novel diagnostic approach that leverages innovative image processing techniques. The urgency of early lung cancer detection is emphasized by its alarming growth worldwide. While computed tomography (CT) surpasses traditional X-ray methods, a comprehensive diagnosis requires a combination of imaging techniques. This research introduces an advanced diagnostic tool implemented through image processing methodologies. The methodology commences with histogram equalization, a crucial step in artifact removal from CT images sourced from a medical database. Accurate lung CT image segmentation, which is vital for cancer diagnosis, follows. The Otsu thresholding method and optimization, employing Colliding Bodies Optimization (CBO), enhance the precision of the segmentation process. A local binary pattern (LBP) is deployed for feature extraction, enabling the identification of nodule sizes and precise locations. The resulting image underwent classification using the densely connected CNN (DenseNet) deep learning algorithm, which effectively distinguished between benign and malignant tumors. The proposed CBO+DenseNet CNN exhibits remarkable performance improvements over traditional methods. Notable enhancements in accuracy (98.17%), specificity (97.32%), precision (97.46%), and recall (97.89%) are observed, as evidenced by the results from the fractional randomized voting model (FRVM). These findings highlight the potential of the proposed model as an advanced diagnostic tool. Its improved metrics promise heightened accuracy in tumor classification and localization. The proposed model uniquely combines Colliding Bodies Optimization (CBO) with DenseNet CNN, enhancing segmentation and classification accuracy for lung cancer detection, setting it apart from traditional methods with superior performance metrics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.